Latest articles on Adcock Ingram

Failed takeover bid takes toll on Adcock

The healthcare company has posted a loss in the wake of a failed stock offer.

PIC wants local ownership to boost economy

The Public Investment Corporation, South Africa's biggest stock investor, says local ownership is key for growing the economy and empowering people.

Shareholders join the battle over Adcock Ingram

The gloves came off this week as two companies and a dominant shareholder battled it out for control of the pharmaceutical company Adcock Ingram.

CFR: Opposition to Adcock offer is to deter foreign buyers

The drawn-out battle for Adcock now sees CFR's offer for Adcock now facing resistance from the PIC, which says the offer is not up to scratch.

Bidvest sues Adcock over CFR deal finance

A day after putting in an offer to acquire part of Adcock Ingram, Bidvest is taking the company to court over an "unlawful" guarantee.

Adcock rebuffs Bidvest, still wants Chile deal

Drugmaker Adcock Ingram says the $1.2-billion takeover bid from CFR Pharmaceuticals is still the best option, despite Bidvest's offer.

Bidvest attempts to torpedo $1.2bn Adcock takeover

A Chilean group's $1.2-billion bid for Adcock Ingram has been challenged by a court action from Bidvest.

Bidvest bids R4-billion for Adcock to counter CFR

Bidvest has put in a R4-billion offer for pharmaceuticals company Adcock, countering that of Chilean company CFR Pharmaceuticals.

Adcock suspends its dividend as purchase talks with CFR go on

Rising import costs led to decreased profits and margins at Adcock, which has suspended its dividend while takeover talks with CFR continue.

PIC still mulling Adcock’s $1.3bn CFR deal

The pharmaceutical company Adcock's biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.

Decision on Adcock offer imminent, says CFR

Chile’s largest drugmaker will decide within weeks whether to make a binding offer for Adcock Ingram Holdings.

SA could score 40% of Adcock, CFR deal

Adcock Ingram has entered into discussions with a Chile-based firm, which could see SA benefit from a possible combined revenue of R12.1-billion.

Adcock profit slides as talks to buy the drugmaker continue

The pharmaceuticals giant has reported its' profit fell 5.4% as it continues takeover talks that may lead to the company being bought.

Adcock takeover offer may push company value to $1.5bn

Adcock Ingram, SA's largest supplier of hospital products, may gain a further 12% from a 30-month high after it got takeover offers.

Drug wars: How Adcock saw its Aspen

A tale of two companies — one saw generics as the future, the other is playing catch-up.

vital information

The Mail & Guardian’s essential coverage of the ongoing coronavirus crisis is free to read for everyone.

If you would like to support us, please consider taking out a subscription.

Latest

Zuma, Zondo play the waiting game

The former president says he will talk once the courts have ruled, but the head of the state capture inquiry appears resigned to letting the clock run out as the commission's deadline nears

Stern warning against Covid greets Mthembu’s death

The ANC has slammed conspiracy theorists and cautioned against showing complacency towards the deadly virus

Lala ngoxolo Mvelase Jackson Mthembu

In his announcement, President Cyril Ramaphosa called the late minister ‘a life-long champion of freedom and democracy’

Press Releases